Hemlibra 60 MG/0.4 ML vial 0.4ML
Ended Awarded Last action
- Contract number
- SPE2DR26F21QK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,572
Award facts
- Contract value 100% obligated
- $3,571.69 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a firm fixed-price delivery order valued at $3,571.69 by the Defense Logistics Agency on January 30, 2026, with an ultimate completion date of February 23, 2026. The contract calls for the delivery of HEMLIBRA 60 mg/0.4 ml vials (0.4 ml) and was awarded competitively without set-aside provisions. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
HEMLIBRA is a specialty hemophilia A treatment used in military and federal healthcare systems. The delivery order represents a routine task order under the established DLA pharmaceutical prime vendor framework, reflecting AmerisourceBergen's role as a critical supplier of prescription medications, vaccines, and medical devices to the Defense Health Agency and other federal healthcare entities. The Defense Logistics Agency's Medical Supply Chain relies on such prime vendor contracts to ensure efficient distribution of essential pharmaceuticals to military treatment facilities and veteran healthcare programs globally.
Quick answers
Who was awarded contract SPE2DR26F21QK?
SPE2DR26F21QK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F21QK worth?
The government has obligated $3,572 on SPE2DR26F21QK.
Is contract SPE2DR26F21QK an order under another contract?
Yes. SPE2DR26F21QK is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21QK competed?
The extent of competition for SPE2DR26F21QK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award